PubMed · 10424840
Power and sample size in cost-effectiveness analysis.
Abstract
For resource allocation under a constrained budget, optimal decision rules for mutually exclusive programs require that the treatment with the highest incremental cost-effectiveness ratio (ICER) below a willingness-to-pay (WTP) criterion be funded. This is equivalent to determining the treatment with the smallest net health cost. The designer of a cost-effectiveness study needs to select a sample size so that the power to reject the null hypothesis, the equality of the net health costs of two treatments, is high. A recently published formula derived under normal distribution theory overstates sample-size requirements. Using net health costs, the authors present simple methods for power analysis based on conventional normal and on nonparametric statistical theory.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
E M Laska, M Meisner, C Siegel. Power and sample size in cost-effectiveness analysis.. https://doi.org/10.1177/0272989x9901900312. https://pubmed.health/record/pubmed%3A10424840/power-and-sample-size-in-cost-effectiveness-analysis
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.